$40.74
-0.61-1.49%
At close: -
$40.64
-0.10-0.25%
After Hours: 4:06 PM EDT
Comments
Loading...
Exelixis Insider Trading Activity | NASDAQ:EXEL | Benzinga
Track the latest Exelixis insider trading activity. Stay informed on recent buys, sells, and market impact for Exelixis stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Exelixis Inc Insiders Doing?
At Exelixis Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 65.30K shares worth $2.85M, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On May 5, 2025, Dana Aftab, the company's CSO/EVP DISC & TRANS RESEARCH sold 1.51K shares for $39 each.
- On May 22, 2025, Tomas Heyman, the company's DIRECTOR sold 4.54K shares for $44.29 each.
- On June 4, 2025, JACK WYSZOMIERSKI, the company's DIRECTOR sold 7.54K shares for $43.09 each.
Ownership Statistics for Exelixis Inc
Shares Outstanding
272.708M
Insider Shares Owned
10.011M
Insider Percentage Owned
3.67%
Institutional Shares Held
156.777M
Institutional Percentage Held
57.5%
| Jun 04, 2025 | Gail Sue Eckhardt | DIRECTOR | -18.84K | $42.74 | -$805.14K | SELL | -46.84% | 21.38K | Jun 02 | View |
| Jun 04, 2025 | JACK WYSZOMIERSKI | DIRECTOR | -7.54K | $43.09 | -$324.68K | SELL | -2.06% | 358.88K | Jun 03 | View |
| May 22, 2025 | Patrick Haley | EVP, COMMERCIAL | -34.39K | $44.06 | -$1.52M | SELL | -7.52% | 422.72K | May 20 | View |
| May 22, 2025 | Tomas Heyman | DIRECTOR | -4.54K | $44.29 | -$201.25K | SELL | -12.28% | 32.47K | May 21 | View |
| May 16, 2025 | GEORGE POSTE | DIRECTOR | 0.00 | $32.88 | -$541.02K | SELL-OPTIONS | 0.00% | 169.02K | May 16 | View |
| May 16, 2025 | Christopher Senner | EVP AND CFO | -41.42K | $32.20 | -$4.57M | SELL | -4.09% | 970.57K | May 15 - May 16 | View |
| May 16, 2025 | STELIOS PAPADOPOULOS | DIRECTOR | 0.00 | $32.22 | -$885.78K | SELL-OPTIONS | 0.00% | 1.28M | May 15 | View |
| May 16, 2025 | Jeffrey Hessekiel | EVP & GENERAL COUNSEL | -59.03K | $45.30 | -$2.67M | SELL | -7.84% | 694.39K | May 15 | View |
| May 16, 2025 | Patrick Haley | EVP, COMMERCIAL | -54.70K | $32.89 | -$5.85M | SELL | -10.69% | 457.11K | May 14 - May 15 | View |
| May 16, 2025 | Amy Peterson | EVP PROD DEV & MED AFF & CMO | -41.08K | $33.57 | -$2.81M | SELL | -8.11% | 465.39K | May 15 - May 16 | View |
| May 05, 2025 | Dana Aftab | CSO/EVP DISC & TRANS RESEARCH | -1.51K | $39.00 | -$58.81K | SELL | -0.22% | 699.02K | May 01 | View |
| Mar 05, 2025 | Patrick Haley | EVP, COMMERCIAL | -10.00K | $38.80 | -$388.00K | SELL | -2.76% | 351.68K | Mar 03 | View |
| Feb 28, 2025 | Julie Smith | DIRECTOR | 0.00 | $29.04 | -$1.32M | SELL-OPTIONS | 0.00% | 10.78K | Feb 27 - Feb 28 | View |
| Feb 28, 2025 | JACK WYSZOMIERSKI | DIRECTOR | 7.11K | $29.15 | -$6.01K | SELL-OPTIONS | 2.03% | 356.61K | Feb 28 | View |
| Feb 26, 2025 | Patrick Haley | EVP, COMMERCIAL | -52.64K | $36.98 | -$1.95M | SELL | -14.36% | 313.96K | Feb 24 | View |
| Feb 26, 2025 | Bob Oliver | DIRECTOR | -3.50K | $28.27 | -$402.57K | SELL | -9.46% | 33.51K | Feb 25 | View |
| Feb 26, 2025 | Dana Aftab | CSO/EVP DISC & TRANS RESEARCH | -26.99K | $36.75 | -$991.77K | SELL | -4.95% | 517.74K | Feb 24 | View |
| Feb 26, 2025 | Christopher Senner | EVP AND CFO | 0.00 | $27.47 | -$508.30K | SELL-OPTIONS | 0.00% | 782.33K | Feb 24 | View |
| Feb 19, 2025 | Mary Beckerle | DIRECTOR | -3.86K | $29.06 | -$231.73K | SELL | -11.25% | 30.41K | Feb 14 | View |
| Feb 19, 2025 | GEORGE POSTE | DIRECTOR | 0.00 | $27.62 | -$226.05K | SELL-OPTIONS | 0.00% | 169.02K | Feb 14 | View |
| Feb 19, 2025 | Maria Freire | DIRECTOR | 0.00 | $28.23 | -$591.82K | SELL-OPTIONS | 0.00% | 91.01K | Feb 14 | View |
| Feb 19, 2025 | Gail Sue Eckhardt | DIRECTOR | -3.86K | $29.13 | -$225.88K | SELL | -11.25% | 30.41K | Feb 14 | View |
| Dec 02, 2024 | Jeffrey Hessekiel | EVP & GENERAL COUNSEL | -44.59K | $27.50 | -$3.32M | SELL | -8.63% | 472.06K | Nov 27 - Nov 29 | View |
| Nov 26, 2024 | Patrick Haley | EVP, COMMERCIAL | -10.00K | $35.27 | -$352.70K | SELL | -3.34% | 289.31K | Nov 22 | View |
| Nov 19, 2024 | Patrick Haley | EVP, COMMERCIAL | -56.26K | $34.54 | -$1.94M | SELL | -15.82% | 299.31K | Nov 15 - Nov 18 | View |
| Nov 07, 2024 | Dana Aftab | CSO/EVP DISC & TRANS RESEARCH | 0.00 | $26.90 | -$1.57M | SELL-OPTIONS | 0.00% | 504.78K | Nov 05 | View |
| Nov 05, 2024 | Jeffrey Hessekiel | EVP & GENERAL COUNSEL | -50.00K | $34.13 | -$1.71M | SELL | -8.60% | 531.32K | Nov 01 | View |
| Nov 05, 2024 | GEORGE POSTE | DIRECTOR | -30.00K | $34.00 | -$1.02M | SELL | -15.07% | 169.02K | Nov 01 | View |
| Nov 01, 2024 | Dana Aftab | CSO/EVP DISC & TRANS RESEARCH | -1.16K | $31.40 | -$36.49K | SELL | -0.23% | 504.78K | Oct 30 | View |
| Oct 30, 2024 | Jeffrey Hessekiel | EVP & GENERAL COUNSEL | -25.00K | $28.39 | -$709.75K | SELL | -4.12% | 581.32K | Oct 28 | View |
| Sep 25, 2024 | Jeffrey Hessekiel | EVP & GENERAL COUNSEL | -25.00K | $26.38 | -$659.50K | SELL | -3.96% | 606.32K | Sep 23 | View |
| Aug 28, 2024 | Jeffrey Hessekiel | EVP, GENERAL COUNSEL & SEC | 0.00 | $25.10 | -$27.60K | SELL-OPTIONS | 0.00% | 631.32K | Aug 26 | View |
| Aug 16, 2024 | Maria Freire | DIRECTOR | -8.25K | $26.56 | -$219.12K | SELL | -8.31% | 91.01K | Aug 14 | View |
| Aug 14, 2024 | Dana Aftab | CSO/EVP DISC & TRANS RESEARCH | -20.88K | $27.06 | -$565.09K | SELL | -3.96% | 505.94K | Aug 12 | View |
| Aug 12, 2024 | GEORGE POSTE | DIRECTOR | -33.73K | $26.89 | -$906.87K | SELL | -14.49% | 199.02K | Aug 08 | View |
| Aug 09, 2024 | Dana Aftab | CSO/EVP DISC & TRANS RESEARCH | 0.00 | $24.70 | -$56.05K | SELL-OPTIONS | 0.00% | 526.83K | Aug 07 | View |
| Aug 09, 2024 | Patrick Haley | EVP, COMMERCIAL | -14.00K | $25.50 | -$357.00K | SELL | -3.70% | 364.57K | Aug 07 | View |
| Aug 09, 2024 | Jeffrey Hessekiel | EVP, GENERAL COUNSEL & SEC | 0.00 | $25.19 | -$124.80K | SELL-OPTIONS | 0.00% | 631.32K | Aug 07 | View |
| Aug 09, 2024 | Christopher Senner | EVP AND CFO | 0.00 | $25.80 | -$347.50K | SELL-OPTIONS | 0.00% | 724.40K | Aug 09 | View |
| Jun 06, 2024 | JACK WYSZOMIERSKI | DIRECTOR | -8.29K | $22.00 | -$182.31K | SELL | -2.32% | 349.50K | Jun 04 | View |
| May 30, 2024 | EDWARD DAVID JOHNSONCaligan Partners LP | DIRECTOR | 425.00K | $20.55 | $8.73M | BUY | 37.98% | 1.54M | May 28 - May 30 | View |
| May 23, 2024 | Julie Smith | DIRECTOR | -27.28K | $21.12 | -$576.15K | SELL | -83.36% | 5.45K | May 21 | View |
| May 22, 2024 | GEORGE POSTE | DIRECTOR | 0.00 | $20.27 | -$16.24K | SELL-OPTIONS | 0.00% | 213.91K | May 21 | View |
| May 22, 2024 | STELIOS PAPADOPOULOS | DIRECTOR | 249.00 | $20.29 | -$11.48K | SELL-OPTIONS | 0.02% | 1.26M | May 20 | View |
| May 15, 2024 | JACK WYSZOMIERSKI | DIRECTOR | 763.00 | $20.47 | -$4.73K | SELL-OPTIONS | 0.23% | 338.95K | May 13 | View |
| Mar 25, 2024 | Alan Garber | DIRECTOR | 4.29K | $21.79 | -$1.39K | SELL-OPTIONS | 13.64% | 35.70K | Mar 21 | View |
| Feb 27, 2024 | Patrick Haley | EVP, COMMERCIAL | 16.33K | $21.45 | -$1.01M | GRANT | 4.31% | 395.51K | Feb 23 | View |
| Feb 22, 2024 | EDWARD DAVID JOHNSONCaligan Partners LP | DIRECTOR | 190.00K | $20.70 | $3.93M | BUY | 20.45% | 1.12M | Feb 21 | View |
| Dec 14, 2023 | Patrick Haley | EVP, COMMERCIAL | -14.15K | $19.73 | -$671.35K | SELL | -4.26% | 318.33K | Dec 12 - Dec 14 | View |
| Dec 14, 2023 | Jeffrey Hessekiel | EVP, GENERAL COUNSEL & SEC | -25.00K | $23.01 | -$575.25K | SELL | -4.47% | 534.34K | Dec 13 | View |
| Dec 04, 2023 | Jeffrey Hessekiel | EVP, GENERAL COUNSEL & SEC | -50.00K | $22.04 | -$1.10M | SELL | -8.21% | 559.34K | Nov 30 - Dec 04 | View |
| Nov 29, 2023 | EDWARD DAVID JOHNSONCaligan Partners LP | DIRECTOR | 0.00 | $21.61 | $0.00 | p / s | 0.00% | 928.91K | Nov 27 | View |
| Sep 01, 2023 | Dana Aftab | CSO/EVP DISC & TRANS RESEARCH | -4.60K | $22.47 | -$103.36K | SELL | -1.12% | 405.78K | Aug 30 | View |
| Aug 07, 2023 | Christopher Senner | EVP AND CFO | 0.00 | $17.67 | -$702.60K | SELL-OPTIONS | 0.00% | 574.35K | Aug 03 - Aug 04 | View |
| Aug 07, 2023 | Patrick Haley | EVP, COMMERCIAL | -30.55K | $20.67 | -$631.53K | SELL | -9.35% | 296.12K | Aug 03 | View |
| Aug 03, 2023 | Jeffrey Hessekiel | EVP, GENERAL COUNSEL & SEC | 0.00 | $17.19 | -$272.42K | SELL-OPTIONS | 0.00% | 572.98K | Aug 01 | View |
| Apr 05, 2023 | Jeffrey Hessekiel | EVP, GENERAL COUNSEL & SEC | 54.72K | $17.38 | -$573.66K | SELL-OPTIONS | 10.35% | 583.43K | Apr 03 - Apr 05 | View |
| Mar 14, 2023 | JACK WYSZOMIERSKI | DIRECTOR | 24.70K | $11.46 | -$2.13K | SELL-OPTIONS | 8.44% | 317.47K | Mar 10 | View |
| Mar 03, 2023 | Jeffrey Hessekiel | EVP, GENERAL COUNSEL & SEC | -50.00K | $15.93 | -$923.09K | SELL | -8.64% | 528.72K | Mar 01 | View |
| Mar 01, 2023 | Dana Aftab | CSO/EVP DISC & TRANS RESEARCH | 0.00 | $16.12 | -$227.70K | SELL-OPTIONS | 0.00% | 357.31K | Feb 27 - Feb 28 | View |
| Feb 23, 2023 | Alan Garber | DIRECTOR | 0.00 | $11.89 | -$447.60K | SELL-OPTIONS | 0.00% | 31.42K | Feb 21 | View |
| Feb 10, 2023 | CARL FELDBAUM | DIRECTOR | 0.00 | $12.04 | -$459.20K | SELL-OPTIONS | 0.00% | 18.70K | Feb 09 | View |
| Feb 08, 2023 | Patrick Haley | EVP, COMMERCIAL | 0.00 | $10.79 | -$329.25K | SELL-OPTIONS | 0.00% | 265.06K | Feb 06 | View |
| Dec 16, 2022 | Peter Lamb | EVP, SCIENTIFIC STRATEGY & CSO | 0.00 | $10.04 | -$233.60K | SELL-OPTIONS | 0.00% | 428.06K | Dec 15 | View |
| Dec 01, 2022 | GEORGE POSTE | DIRECTOR | 0.00 | $11.49 | -$415.20K | SELL-OPTIONS | 0.00% | 193.19K | Nov 29 | View |
| Nov 17, 2022 | Jeffrey Hessekiel | EVP, GENERAL COUNSEL & SEC | -43.18K | $21.73 | -$938.21K | SELL | -6.92% | 580.64K | May 17 - Nov 15 | View |
| Sep 14, 2022 | Patrick Haley | EVP, COMMERCIAL | 0.00 | $12.08 | -$469.20K | SELL-OPTIONS | 0.00% | 272.24K | Sep 12 | View |
| Jun 01, 2022 | Patrick Haley | EVP, COMMERCIAL | -18.81K | $18.21 | -$342.57K | SELL | -6.99% | 250.47K | May 27 | View |
| May 13, 2022 | LANCE WILLSEY | DIRECTOR | 0.00 | $11.39 | -$660.80K | SELL-OPTIONS | 0.00% | 424.42K | May 12 | View |
| Apr 06, 2022 | JACK WYSZOMIERSKI | DIRECTOR | 33.30K | $13.06 | -$28.81K | SELL-OPTIONS | 13.88% | 273.19K | Apr 04 | View |
| Apr 04, 2022 | Patrick Haley | EVP, COMMERCIAL | 0.00 | $14.46 | -$330.10K | SELL-OPTIONS | 0.00% | 279.84K | Mar 31 - Apr 01 | View |
| Mar 30, 2022 | Jeffrey Hessekiel | EVP, GENERAL COUNSEL & SEC | -18.00K | $22.00 | -$396.00K | SELL | -2.88% | 606.24K | Mar 28 - Mar 29 | View |
| Mar 03, 2022 | Alan Garber | DIRECTOR | 18.70K | $12.06 | -$322.12K | SELL-OPTIONS | 147.03% | 31.42K | Mar 01 | View |
| Feb 28, 2022 | Jeffrey Hessekiel | EVP AND GENERAL COUNSEL | -18.00K | $20.00 | -$360.00K | SELL | -3.13% | 556.36K | Feb 24 | View |
| Feb 28, 2022 | Patrick Haley | EVP, COMMERCIAL | -31.24K | $19.53 | -$610.08K | SELL | -13.00% | 209.12K | Feb 25 | View |
| Feb 24, 2022 | STELIOS PAPADOPOULOS | DIRECTOR | -84.52K | $19.56 | -$1.65M | SELL | -6.48% | 1.22M | Feb 22 | View |
| Feb 24, 2022 | CARL FELDBAUM | DIRECTOR | 0.00 | $11.31 | -$327.20K | SELL-OPTIONS | 0.00% | 8.52K | Feb 22 | View |
| Feb 04, 2022 | Patrick Haley | EVP, COMMERCIAL | 0.00 | $9.90 | -$960.60K | SELL-OPTIONS | 0.00% | 255.89K | Feb 03 | View |
| Dec 17, 2021 | Peter Lamb | EVP, SCIENTIFIC STRATEGY & CSO | 14.10K | $11.81 | -$612.41K | SELL-OPTIONS | 3.85% | 380.28K | Dec 15 | View |
| Nov 26, 2021 | Patrick Haley | EVP, COMMERCIAL | -17.24K | $17.25 | -$297.32K | SELL | -6.49% | 248.45K | Nov 24 | View |
| Nov 23, 2021 | CARL FELDBAUM | DIRECTOR | 0.00 | $10.38 | -$289.80K | SELL-OPTIONS | 0.00% | 8.52K | Nov 19 | View |
| Nov 17, 2021 | Peter Lamb | EVP, SCIENTIFIC STRATEGY & CSO | -62.16K | $12.15 | -$1.69M | SELL | -14.51% | 366.18K | Nov 15 | View |
| Nov 03, 2021 | Jeffrey Hessekiel | EVP AND GENERAL COUNSEL | -5.12K | $22.03 | -$112.73K | SELL | -0.80% | 633.82K | Nov 01 | View |
| Oct 15, 2021 | Peter Lamb | EVP, SCIENTIFIC STRATEGY & CSO | 0.00 | $14.07 | -$746.23K | SELL-OPTIONS | 0.00% | 428.35K | Oct 15 | View |
| Oct 15, 2021 | Jeffrey Hessekiel | EVP AND GENERAL COUNSEL | -12.88K | $22.02 | -$283.68K | SELL | -1.98% | 638.94K | Oct 15 | View |
| Sep 17, 2021 | Patrick Haley | EVP, COMMERCIAL | 0.00 | $11.03 | -$466.50K | SELL-OPTIONS | 0.00% | 291.64K | Sep 16 | View |
| Sep 17, 2021 | Peter Lamb | EVP, SCIENTIFIC STRATEGY & CSO | 0.00 | $13.34 | -$676.88K | SELL-OPTIONS | 0.00% | 406.57K | Sep 15 | View |
| Aug 18, 2021 | Peter Lamb | EVP, SCIENTIFIC STRATEGY & CSO | 0.00 | $10.17 | -$909.70K | SELL-OPTIONS | 0.00% | 406.57K | Aug 16 | View |
| Jul 16, 2021 | Peter Lamb | EVP, SCIENTIFIC STRATEGY & CSO | 0.00 | $9.68 | -$934.20K | SELL-OPTIONS | 0.00% | 406.57K | Jul 15 | View |
| Jun 22, 2021 | Peter Lamb | EVP, SCIENTIFIC STRATEGY & CSO | 0.00 | $12.04 | -$1.22M | SELL-OPTIONS | 0.00% | 406.57K | Jun 17 | View |
| May 18, 2021 | Patrick Haley | EVP, COMMERCIAL | -17.62K | $24.87 | -$438.23K | SELL | -5.70% | 291.64K | May 15 - May 18 | View |
| May 17, 2021 | Maria Freire | DIRECTOR | -8.28K | $25.01 | -$206.96K | SELL | -20.63% | 31.83K | May 11 | View |
| May 17, 2021 | VINCENT MARCHESI | DIRECTOR | 0.00 | $15.67 | -$749.60K | SELL-OPTIONS | 0.00% | 66.11K | May 14 | View |
| May 17, 2021 | GEORGE POSTE | DIRECTOR | -40.80K | $24.97 | -$1.02M | SELL | -20.61% | 157.19K | May 14 | View |
| May 14, 2021 | Gisela Schwab | PRES, PROD DEV & MED AFF & CMO | 0.00 | $13.64 | -$2.35M | SELL-OPTIONS | 0.00% | 628.96K | May 13 | View |
| May 13, 2021 | STELIOS PAPADOPOULOS | DIRECTOR | 99.23K | $14.62 | -$6.39K | SELL-OPTIONS | 8.35% | 1.29M | May 11 | View |
| Apr 28, 2021 | Gisela Schwab | PRES, PROD DEV & MED AFF & CMO | 0.00 | $13.35 | -$1.17M | SELL-OPTIONS | 0.00% | 628.36K | Apr 26 | View |
| Apr 28, 2021 | Patrick Haley | EVP, COMMERCIAL | -7.67K | $25.03 | -$191.85K | SELL | -2.43% | 308.04K | Apr 26 | View |
| Apr 28, 2021 | Jeffrey Hessekiel | EVP AND GENERAL COUNSEL | -18.00K | $25.03 | -$450.54K | SELL | -2.78% | 629.25K | Apr 26 | View |
| Apr 02, 2021 | Peter Lamb | EVP, SCIENTIFIC STRATEGY & CSO | 0.00 | $12.33 | -$1.28M | SELL-OPTIONS | 0.00% | 406.57K | Apr 01 | View |
| Apr 02, 2021 | Gisela Schwab | PRES, PROD DEV & MED AFF & CMO | 0.00 | $12.35 | -$1.06M | SELL-OPTIONS | 0.00% | 628.36K | Apr 01 | View |
| Mar 31, 2021 | JACK WYSZOMIERSKI | DIRECTOR | 33.78K | $13.01 | -$5.62K | SELL-OPTIONS | 17.08% | 231.59K | Mar 29 | View |
| Mar 17, 2021 | Alan Garber | DIRECTOR | 0.00 | $13.49 | -$808.80K | SELL-OPTIONS | 0.00% | 12.72K | Mar 15 | View |
| Mar 03, 2021 | Peter Lamb | EVP, SCIENTIFIC STRATEGY & CSO | 0.00 | $11.90 | -$1.33M | SELL-OPTIONS | 0.00% | 357.18K | Mar 01 | View |
| Feb 26, 2021 | CHARLES COHEN | DIRECTOR | 0.00 | $13.04 | -$772.40K | SELL-OPTIONS | 0.00% | 181.38K | Feb 24 | View |
| Feb 24, 2021 | VINCENT MARCHESI | DIRECTOR | -24.10K | $22.29 | -$537.12K | SELL | -26.71% | 66.11K | Feb 22 | View |
| Feb 24, 2021 | LANCE WILLSEY | DIRECTOR | -50.00K | $12.65 | -$1.84M | SELL | -10.54% | 424.42K | Feb 16 - Feb 23 | View |
| Feb 19, 2021 | Gisela Schwab | PRES, PROD DEV & MED AFF & CMO | 0.00 | $12.06 | -$2.07M | SELL-OPTIONS | 0.00% | 555.48K | Feb 17 - Feb 18 | View |
| Feb 17, 2021 | Patrick Haley | EVP, COMMERCIAL | -46.40K | $21.58 | -$1.00M | SELL | -15.34% | 256.13K | Feb 12 - Feb 15 | View |
| Feb 17, 2021 | CARL FELDBAUM | DIRECTOR | 0.00 | $12.67 | -$371.60K | SELL-OPTIONS | 0.00% | 8.52K | Feb 16 | View |
| Feb 03, 2021 | Peter Lamb | EVP, SCIENTIFIC STRATEGY & CSO | 0.00 | $11.89 | -$1.32M | SELL-OPTIONS | 0.00% | 300.23K | Feb 01 | View |
| Jan 14, 2021 | Christopher Senner | EVP AND CFO | 0.00 | $14.33 | -$640.20K | SELL-OPTIONS | 0.00% | 248.32K | Jan 12 | View |
| Jan 06, 2021 | Peter Lamb | EVP, SCIENTIFIC STRATEGY & CSO | 0.00 | $11.01 | -$1.21M | SELL-OPTIONS | 0.00% | 300.23K | Jan 04 | View |
| Dec 22, 2020 | Peter Lamb | — | 0.00 | $10.86 | -$1.19M | OPTION EXERCISE | 0.00% | 300.23K | Dec 18 | View |
| Nov 25, 2020 | VINCENT MARCHESI | — | 0.00 | $12.16 | -$507.25K | OPTION EXERCISE | 0.00% | 90.21K | Nov 24 | View |
| Nov 13, 2020 | JACK WYSZOMIERSKI | — | 28.40K | $13.21 | -$337.55K | OPTION EXERCISE | 16.77% | 197.81K | Nov 10 | View |
| Oct 23, 2020 | Jeffrey Hessekiel | — | 0.00 | $14.61 | -$583.41K | OPTION EXERCISE | 0.00% | 344.02K | Oct 21 | View |
| Oct 09, 2020 | Christopher Senner | — | 0.00 | $14.33 | -$213.40K | OPTION EXERCISE | 0.00% | 130.60K | Oct 08 | View |
| Sep 24, 2020 | Jeffrey Hessekiel | — | 0.00 | $16.70 | -$193.57K | OPTION EXERCISE | 0.00% | 344.02K | Sep 22 | View |
| Sep 23, 2020 | Patrick Haley | — | 0.00 | $15.96 | -$94.86K | OPTION EXERCISE | 0.00% | 126.22K | Sep 21 | View |
| Sep 16, 2020 | Jeffrey Hessekiel | — | 0.00 | $16.69 | -$376.80K | OPTION EXERCISE | 0.00% | 344.02K | Sep 16 | View |
| Sep 15, 2020 | Christopher Senner | — | 0.00 | $14.33 | -$426.80K | OPTION EXERCISE | 0.00% | 130.60K | Sep 15 | View |
| Jul 22, 2020 | Patrick Haley | — | -3.15K | $25.36 | -$79.91K | SELL | -2.50% | 122.84K | Jul 20 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
